Geneos Wealth Management’s Convergence Long/Short Equity ETF CLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.59K Hold
135
– – ﹤0.01% 2669
2026
Q2
$4.61K Sell
135
-94
-41% -$3.04K ﹤0.01% 2206
2026
Q1
$6.44K Buy
+229
New +$6.44K ﹤0.01% 2106

Other funds holding CLSE

Geneos Wealth Management's CLSE Position: Q3 2026 in Review

Geneos Wealth Management held its Convergence Long/Short Equity ETF (CLSE) position steady in Q3 2026 at 135 shares worth $4.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2669.

Geneos Wealth Management first reported a position in CLSE in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.44K in Q1 2026. 150 funds tracked by Wall St. Rank hold CLSE as of Q3 2026.

  • Geneos Wealth Management held 135 shares of Convergence Long/Short Equity ETF worth $4.59K as of Q3 2026.
  • Geneos Wealth Management left its Convergence Long/Short Equity ETF share count unchanged in Q3 2026.
  • Convergence Long/Short Equity ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2669 holding.
  • Geneos Wealth Management first reported a position in Convergence Long/Short Equity ETF in Q1 2026 and has held it in 3 quarters since.
  • Geneos Wealth Management's Convergence Long/Short Equity ETF position peaked at $6.44K in Q1 2026.
  • 150 funds tracked by Wall St. Rank held Convergence Long/Short Equity ETF as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.